| Genetic and transcriptional evolution alters cancer cell line drug response U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Nature 560 (7718), 325-330, 2018 | 821 | 2018 |
| Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition Y Cohen-Sharir, JM McFarland, M Abdusamad, C Marquis, SV Bernhard, ... Nature 590 (7846), 486-491, 2021 | 169 | 2021 |
| Randomised, double-blind, placebo-controlled trial of probiotics to eliminate COVID-19 transmission in exposed household contacts (PROTECT-EHC): a clinical trial protocol H Tang, L Bohannon, M Lew, D Jensen, SH Jung, A Zhao, AD Sung, ... BMJ open 11 (5), e047069, 2021 | 35 | 2021 |
| Daily Lactobacillus probiotic versus placebo in COVID-19-exposed household contacts (PROTECT-EHC): a randomized clinical trial PE Wischmeyer, H Tang, Y Ren, L Bohannon, ZE Ramirez, ... MedRxiv, 2022.01. 04.21268275, 2022 | 23 | 2022 |
| Racial differences in Helicobacter pylori prevalence in the US: a systematic review HS Brown, S Cantrell, H Tang, M Epplein, KS Garman Gastro hep advances 1 (5), 857-868, 2022 | 15 | 2022 |
| Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease ZC Holmes, H Tang, C Liu, A Bush, BC Neubert, Y Jiao, M Covington, ... Blood, The Journal of the American Society of Hematology 140 (21), 2300-2304, 2022 | 13 | 2022 |
| A novel Bromine-Containing paroxetine analogue provides mechanistic clues for binding ambiguity at the central primary binding site of the serotonin transporter RD Slack, AM Abramyan, H Tang, S Meena, BA Davis, A Bonifazi, ... ACS chemical neuroscience 10 (9), 3946-3952, 2019 | 11 | 2019 |
| Daily lactobacillus probiotic versus placebo in COVID-19-exposed household contacts (PROTECTEHC): a randomized clinical trial [preprint]. 2022; medRxiv: 2022.01. 04.21268275 PE Wischmeyer, H Tang, Y Ren, L Bohannon, ZE Ramirez, ... Google Scholar, 2022 | 9 | 2022 |
| Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial PE Wischmeyer, H Tang, Y Ren, L Bohannon, D Jiang, M Bergens, ... Clinical Nutrition 43 (1), 259-267, 2024 | 8 | 2024 |
| Geriatric assessment reveals actionable impairments in hematopoietic stem cell transplantation candidates age 18 to 80 years MV Lew, Y Ren, YP Lowder, S Siamakpour-Reihani, S Ramalingam, ... Transplantation and cellular therapy 28 (8), 498. e1-498. e9, 2022 | 7 | 2022 |
| Female sex is associated with improved long-term survival following allogeneic hematopoietic stem cell transplantation P Islam, H Tang, H Jin, F Cao, LM Bohannon, Y Ren, NJ Chao, T Choi, ... Transplantation and cellular therapy 27 (9), 784. e1-784. e7, 2021 | 7 | 2021 |
| Decreased mortality in 1-year survivors of umbilical cord blood transplant vs. matched related or matched unrelated donor transplant in patients with hematologic malignancies L Bohannon, H Tang, K Page, Y Ren, SH Jung, A Artica, A Britt, P Islam, ... Transplantation and cellular therapy 27 (8), 669. e1-669. e8, 2021 | 6 | 2021 |
| Selective vulnerability of aneuploid human cancer cells to inhibition of the spindle assembly checkpoint Y Cohen-Sharir, JM McFarland, M Abdusamad, C Marquis, H Tang, ... BioRXiv, 2020.06. 18.159038, 2020 | 6 | 2020 |
| Anwesha Nag, Guillaume Kugener, Beth Cimini, Peter Tsvetkov, Yosef E U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Maruvka, Ryan O’Rourke, Anthony Garrity, Andrew A. Tubelli, Pratiti …, 2018 | 6 | 2018 |
| Home-based hematopoietic cell transplantation in the United States AD Sung, VK Giri, H Tang, KR Nichols, MV Lew, L Bohannon, Y Ren, ... Transplantation and cellular therapy 28 (4), 207. e1-207. e8, 2022 | 5 | 2022 |
| SAT0162 switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis J O'Dell, A Kivitz, T Takeuchi, Y Tanaka, I Louw, T Tiabut, S Nakashima, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 831-831, 2017 | 5 | 2017 |
| Predictive performance of CAR-OLT and CAD-LT scores for post-transplant adverse cardiovascular events in a large transplant center H Tang, C Shi, S Chapin, S Panchal, X Yu, LB VanWagner, M Serper, ... Liver Transplantation 29 (9), 1008-1011, 2023 | 3 | 2023 |
| The impact of weight loss programs on BMI trajectory in patients with metabolic dysfunction-associated steatotic liver disease: A Veterans health Administration study H Tang, DE Kaplan, N Mahmud Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 1 | 2022 |
| Preliminary results of a phase 1, first-in-human, dose escalation study of the anti-CCR8 cytolytic antibody, CHS-114 (formerly SRF114) in patients with advanced solid tumors. A Patnaik, J Call, WB McKean, DW Rasco, PJ Oppelt, VN Kapoor, ... Journal of Clinical Oncology 42 (16_suppl), 2664-2664, 2024 | | 2024 |
| Su1556 WEIGHT LOSS PROGRAMS AND BMI TRAJECTORY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A VETERANS HEALTH ADMINISTRATION STUDY H Tang, DE Kaplan, N Mahmud Gastroenterology 166 (5), S-1638, 2024 | | 2024 |
